Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Barbara Šalingová"'
Autor:
Adriana Adamičková, Jan Kyselovic, Matúš Adamička, Nikola Chomaničová, Simona Valášková, Barbara Šalingová, Miroslava Molitorisová, Zdenko Červenák, Ľuboš Danišovič, Andrea Gažová
Publikováno v:
Medicina, Vol 60, Iss 5, p 787 (2024)
Background and Objectives: Stem cell-based regeneration strategies have shown therapeutic efficacy in various fields of regenerative medicine. These include bone healing after bone augmentation, often complicated by pain, which is managed by using no
Externí odkaz:
https://doaj.org/article/84e11285d51443f3b3ae21b6c2759100
Autor:
Zdenko Červenák, Filip Červenák, Adriana Adamičková, Barbara Šalingová, Andrea Gažová, Ján Kyselovič
Publikováno v:
BMC Cardiovascular Disorders, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background Quantitative RT-PCR is a valuable tool for assessing the gene expression in different human tissues, particularly due to its exceptional sensitivity, accuracy and reliability. However, the choice of adequate control for normalizat
Externí odkaz:
https://doaj.org/article/0833aa58abaf47d790a744b4d60f2e80
Autor:
Barbara Šalingová, Jan Kyselovic, Adriana Adamickova, Filip Červenák, Andrea Gažová, Zdenko Červenák
Publikováno v:
BMC cardiovascular disorders. 22(1)
Background Quantitative RT-PCR is a valuable tool for assessing the gene expression in different human tissues, particularly due to its exceptional sensitivity, accuracy and reliability. However, the choice of adequate control for normalization is a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5047527474d74391e689ca741778ef8d
https://pubmed.ncbi.nlm.nih.gov/35439923
https://pubmed.ncbi.nlm.nih.gov/35439923
Autor:
Daniela Rehakova, Petr Matula, Lenka Tesarova, Irena Koutná, Simon Farkas, Pavel Matula, Katerina Kutalkova, Barbara Šalingová, Eva Vavreckova, Pavel Šimara, Lenka Veverková
Publikováno v:
Stem Cells and Development
New approaches in regenerative medicine and vasculogenesis have generated a demand for sufficient numbers of human endothelial cells (ECs). ECs and their progenitors reside on the interior surface of blood and lymphatic vessels or circulate in periph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f0f57848785d7e88b4838eb63a162c1
https://pubmed.ncbi.nlm.nih.gov/29117787
https://pubmed.ncbi.nlm.nih.gov/29117787
Autor:
Zuzana Nichtova, Lenka Veverková, Petr Synek, Pavel Šimara, Ondrej Jasek, Irena Koutná, Lenka Zajíčková, Miroslava Sedláčková, Pavel Matula, Barbara Šalingová
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 14, p 3536 (2019)
International Journal of Molecular Sciences
Volume 20
Issue 14
International Journal of Molecular Sciences
Volume 20
Issue 14
Background: Endothelial progenitor cells (EPCs) were indicated in vascular repair, angiogenesis of ischemic organs, and inhibition of formation of initial hyperplasia. Differentiation of endothelial cells (ECs) from human induced pluripotent stem cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e655d19a3dac6b5a48d8102967e3b486
https://doi.org/10.3390/ijms20143536
https://doi.org/10.3390/ijms20143536
Autor:
Vladimír Ulman, Peter Kovac, Petr Matula, David Svoboda, Barbara Šalingová, Irena Koutná, Lenka Tesarova
Publikováno v:
ICIP
Cardiovascular diseases belong to the most widespread illnesses in the developed countries. Therefore, the regenerative medicine and tissue modeling applications are highly interested in studying the ability of endothelial cells, derived from human s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eca477691a2208376c21b8ab08ce7dde
https://doi.org/10.1109/icip.2016.7532946
https://doi.org/10.1109/icip.2016.7532946
Autor:
Pavel Šimara, Lenka Tesarova, Barbara Šalingová, Martina Madarasova, Irena Koutná, Stanislav Stejskal
Publikováno v:
Journal of Stem Cell Research & Therapy.
Cardiovascular disease has become the leading cause of death in high income countries worldwide and the available treatment is not able to provide a complete recovery. Tissue engineering offers a possibility to construct autologous vein replacements
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ae2ad724b7de05e314fbc350c2ed93e
https://doi.org/10.4172/2157-7633.1000185
https://doi.org/10.4172/2157-7633.1000185